Neumora Therapeutics, Inc. (NMRA) insider trading

By person

8 insiders · 16 transactions

16.8×

Paul L. Berns holds 16.8 times base salary in stock. $11.80M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul L. Berns last reported holding, valued at $1.60, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daljit Singh Aurora

See Remarks

—

$1.03M (13) scheduled

−$1.03M

48,750

0.0259%

$77.80K

−77.0%

Paul L Berns

See Remarks

—

$34.46K (1)

−$34.46K

7,395,185

3.94%

$11.80M

−5.4%

Joshua Pinto

President & CEO

—

$21.09K (1)

−$21.09K

209,950

0.1117%

$335.04K

−6.3%

Michael Lee Milligan

See Remarks

—

$5.12K (1) scheduled

−$5.12K

21,034

0.0112%

$33.57K

−14.0%

Kristina Burow

Director

—

6,046,907

3.22%

$9.65M

+46.4%

ARCH Venture Partners XII, LLC entity

10% owner

—

6,046,907

3.22%

$9.65M

+46.4%

ARCH Venture Partners X, LLC entity

10% owner

—

6,046,907

3.22%

$9.65M

+46.4%

Robert A. Lenz

Head of R&D

—

309,092

0.1645%

$493.25K

−1.8%

Neumora Therapeutics, Inc.

What the insiders did Net selling

By person